Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Adaptimmune Therapeutics PLC | 986,352 | reported | 28 Aug 2025 | tx 42+14,537,172−314,167 |
| DISCOVERY PARTNERS INTERNATIONAL INC | 200,000 | reported | 19 Oct 2015 | tx 1+200,000 |
| ARDELYX, INC. | 54,059 | reported | 18 Jun 2025 | tx 24+710,511 |
| MEDIMMUNE INC /DE | 0 | reported | 18 Jun 2007 | tx 12+130,000−290,036 |
| SALIX PHARMACEUTICALS LTD | 0 | reported | 01 Apr 2015 | tx 4+17,279−31,258 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 Aug 2025 | SALE | Adaptimmune Therapeutics PLC | 207,000 | 0.01 USD | |
| 18 Jun 2025 | GRANT_AWARD | ARDELYX, INC. | 19,390 | 0.00 USD | |
| 18 Jun 2025 | GRANT_AWARD | ARDELYX, INC. | 41,551 | 0.00 USD | |
| 18 Jun 2025 | GRANT_AWARD | ARDELYX, INC. | 54,059 | 0.00 USD | deriv |
| 20 Feb 2025 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 1,612,032 | 0.00 USD | deriv |
| 20 Feb 2025 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 1,074,696 | 0.00 USD | deriv |
| 17 Jan 2025 | SALE | Adaptimmune Therapeutics PLC | 5,584 | 0.58 USD | |
| 13 Jan 2025 | SALE | Adaptimmune Therapeutics PLC | 5,471 | 0.59 USD | |
| 13 Jan 2025 | SALE | Adaptimmune Therapeutics PLC | 4,268 | 0.59 USD | |
| 15 Jan 2025 | SALE | Adaptimmune Therapeutics PLC | 9,803 | 0.57 USD | |
| 14 Jun 2024 | GRANT_AWARD | ARDELYX, INC. | 11,023 | 0.00 USD | |
| 14 Jun 2024 | GRANT_AWARD | ARDELYX, INC. | 40,243 | 0.00 USD | deriv |
| 17 Jan 2024 | SALE | Adaptimmune Therapeutics PLC | 13,599 | 0.67 USD | |
| 17 Jan 2024 | SALE | Adaptimmune Therapeutics PLC | 5,309 | 0.67 USD | |
| 16 Jan 2024 | SALE | Adaptimmune Therapeutics PLC | 4,681 | 0.79 USD | |
| 15 Jan 2024 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 565,416 | 0.00 USD | deriv |
| 15 Jan 2024 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 2,544,432 | 0.00 USD | deriv |
| 12 Jan 2024 | SALE | Adaptimmune Therapeutics PLC | 5,220 | 0.85 USD | |
| 11 Jan 2024 | SALE | Adaptimmune Therapeutics PLC | 4,009 | 0.84 USD | |
| 15 Jun 2023 | GRANT_AWARD | ARDELYX, INC. | 16,581 | 0.00 USD | |
| 15 Jun 2023 | GRANT_AWARD | ARDELYX, INC. | 49,237 | 0.00 USD | deriv |
| 17 Jan 2023 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 1,407,072 | 0.00 USD | deriv |
| 17 Jan 2023 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 314,256 | 0.00 USD | deriv |
| 17 Jan 2023 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 202,800 | 0.00 USD | deriv |
| 17 Jan 2023 | SALE | Adaptimmune Therapeutics PLC | 4,440 | 1.86 USD |
1 purchase reported after at least 12 months of silence — most recent on 14 Dec 2020.